Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...

Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, ...

Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

Eli Lilly's oral selective oestrogen receptor degrader (SERD) imlunestrant (Inluriyo), has received a second FDA approval, ...

Leela Barham looks at the discussion on non-submissions to the HTA body NICE, informed by the latest metrics for the UK’s ...

That number confirmed something I've believed for a while: we built the chain to protect the product, not to reassure the ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) – one of Bayer's top growth prospects – is already approved ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...